Biofrontera Inc(BFRI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BFRI Biofrontera Inc

Trading 06-26 13:22:14 EDT

0.9010

-0.0490

-5.16%

High0.9800	Low0.9000	Vol26.72K
Open0.9500	D1 Closing0.9500	Amplitude8.42%
Mkt Cap4.59M	Tradable Cap2.36M	Total Shares5.09M
T/O25.20K	T/O Rate1.02%	Tradable Shares2.62M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"BFRI","market":"US","secType":"STK","nameCN":"Biofrontera Inc","latestPrice":0.901,"timestamp":1719421352050,"preClose":0.95,"halted":0,"volume":26722,"delay":0,"floatShares":2624046,"shares":5089413,"eps":-10.899437,"marketStatus":"Trading","change":-0.049,"latestTime":"06-26 13:22:14 EDT","open":0.95,"high":0.98,"low":0.9,"amount":25198.97880834,"amplitude":0.084211,"askPrice":0.935,"askSize":100,"bidPrice":0.902,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-10.899437,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Market Trading","tradingStatus":3,"beginTime":1719432000000},"marketStatusCode":2,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":0.95,"preHourTrading":{"tag":"盘前","latestPrice":0.9,"preClose":0.95,"latestTime":"08:00 EDT","volume":1201,"amount":1080.9,"timestamp":1719403201391},"postHourTrading":{"tag":"盘后","latestPrice":0.95,"preClose":0.95,"latestTime":"18:46 EDT","volume":58,"amount":55.0368,"timestamp":1719355601539},"volumeRatio":1.546038,"impliedVol":4.5486,"impliedVolPercentile":0.8333},"requestUrl":"/m/hq/s/BFRI/tweets","defaultTab":"tweets","newsList":[{"id":"2445003656","title":"Biofrontera Unveils RhodoLED® XL Lamp, Eyes Market Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2445003656","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445003656?lang=en_us&edition=fundamental","pubTime":"2024-06-24 22:53","pubTimestamp":1719240832,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) has provided an update. Biofrontera Inc. has announced the release of its new FDA-approved product, the RhodoLED® XL, a cutting-...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biofrontera-unveils-rhodoled-xl-lamp-eyes-market-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biofrontera-unveils-rhodoled-xl-lamp-eyes-market-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BFRI"],"gpt_icon":0},{"id":"2445355076","title":"Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp","url":"https://stock-news.laohu8.com/highlight/detail?id=2445355076","media":"GlobeNewswire","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2445355076?lang=en_us&edition=fundamental","pubTime":"2024-06-24 20:30","pubTimestamp":1719232200,"startTime":"0","endTime":"0","summary":"The RhodoLED XL is approved by the FDA in combination with Ameluz  topical gel, 10% for photodynamic therapy  of actinic keratoses of mild-to-moderate severity on the face and scalp. Biofrontera launched the commercial distribution of the RhodoLED XL on June 10, 2024, shipping the first three machines within 1 week of launch. WOBURN, MA, June 24, 2024  -- Biofrontera Inc. , a biopharmaceutical company specializing in the commercialization of dermatologic products, is proud to announce the launch of its FDA-approved RhodoLED XL, a red light emitting LED lamp.Biofrontera’s PDT drug, Ameluz, is approved by the FDA in combination with either member of the RhodoLED lamp family. The introduction of the RhodoLED XL provides the option to illuminate a larger area in a single on-label Ameluz PDT treatment.Certain statements in this press release may constitute “forward-looking statements” within the meaning of the United States Private Securities Litigation Reform Act of","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/9wAHhsn9s56VnbxTHzpSeQ--~B/aD0xNjY7dz0zMzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/563afe9fd390321ec875ea143ff46dd4","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/9wAHhsn9s56VnbxTHzpSeQ--~B/aD0xNjY7dz0zMzM7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/563afe9fd390321ec875ea143ff46dd4"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biofrontera-announces-launch-fda-approved-123000344.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PDT","BFRI","BFRIW","BK4007"],"gpt_icon":0},{"id":"2443985803","title":"Biofrontera Stockholders Approve Key Governance Decisions","url":"https://stock-news.laohu8.com/highlight/detail?id=2443985803","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2443985803?lang=en_us&edition=fundamental","pubTime":"2024-06-15 05:19","pubTimestamp":1718399978,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Biofrontera (BFRI). At the Company’s Annual Meeting, stockholders cast their votes on several key issues. John ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biofrontera-stockholders-approve-key-governance-decisions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biofrontera-stockholders-approve-key-governance-decisions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BFRI","BK4007"],"gpt_icon":0},{"id":"2441971509","title":"Analysts Offer Insights on Healthcare Companies: Biofrontera (BFRI), Gilead Sciences (GILD) and Ventyx Biosciences (VTYX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2441971509","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2441971509?lang=en_us&edition=fundamental","pubTime":"2024-06-06 20:03","pubTimestamp":1717675426,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biofrontera (BFRI – Research Report), Gilead Science...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biofrontera-bfri-gilead-sciences-gild-and-ventyx-biosciences-vtyx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biofrontera-bfri-gilead-sciences-gild-and-ventyx-biosciences-vtyx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0109394709.USD","GILD","LU0889565916.HKD","LU1066053197.SGD","BK4578","BK4585","HCSG","BK4532","LU1839511570.USD","BK4137","BK4007","BK4588","BK4139","IE00BSNM7G36.USD","VTYX","LU0058720904.USD","LU2087621335.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BK4550","LU1585245621.USD","BFRI","LU0234570918.USD","LU1066051498.USD","LU1430594728.SGD","LU0320765992.SGD","LU1571399168.USD","LU2468319806.SGD","BK4583","IE00BKVL7J92.USD","BK4566","BK4568"],"gpt_icon":0},{"id":"2435695821","title":"Biofrontera GAAP EPS of -$2.88, revenue of $7.9M","url":"https://stock-news.laohu8.com/highlight/detail?id=2435695821","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435695821?lang=en_us&edition=fundamental","pubTime":"2024-05-16 05:46","pubTimestamp":1715809575,"startTime":"0","endTime":"0","summary":"Biofrontera press release  (NASDAQ:BFRI): Q1  GAAP EPS of -$2.88.\nRevenue of $7.9M (-9.2% Y/Y).\nThe company anticipates that sales of its new RhodoLED XL lamp will begin in the second quarter of 2024.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4107055-biofrontera-gaap-eps-of-2_88-revenue-of-7_9m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BFRI"],"gpt_icon":0},{"id":"2435698521","title":"Biofrontera Q1 2024 GAAP EPS $(2.88) Misses $(1.17) Estimate, Sales $7.912M Miss $10.857M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2435698521","media":"Benzinga","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435698521?lang=en_us&edition=fundamental","pubTime":"2024-05-16 05:19","pubTimestamp":1715807967,"startTime":"0","endTime":"0","summary":"Biofrontera (NASDAQ:BFRI) reported quarterly losses of $(2.88) per share which missed the analyst consensus estimate of $(1.17) by 146.15 percent. This is a 48.57 percent increase over losses of $(5.60) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/05/38860045/biofrontera-q1-2024-gaap-eps-2-88-misses-1-17-estimate-sales-7-912m-miss-10-857m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI"],"gpt_icon":0},{"id":"2435660528","title":"Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2435660528","media":"ACCESSWIRE","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435660528?lang=en_us&edition=fundamental","pubTime":"2024-05-16 04:45","pubTimestamp":1715805900,"startTime":"0","endTime":"0","summary":"Conference call begins at 10:00 a.m. Eastern time on Thursday, May 16, 2024. WOBURN, MA / ACCESSWIRE / May 15, 2024 / Biofrontera Inc.  , a biopharmaceutical company specializing in the commercialization of dermatologic products, today reported financial results for the three months ended March 31, 2024 and provided a business update.Highlights from the first quarter of 2024 and subsequent weeks included the following:. Total revenues for the first quarter of 2024 were $7.9 million, a 9% decrease from the same period of the prior year primarily driven by reimbursement headwinds our customers experienced due to the Change Healthcare data breach. Cash and cash equivalents were $3.8 million as of March 31, 2024, compared with $1.3 million on December 31, 2023. \"We have focused much of our efforts over the last year on developing new accounts and in the first quarter of this year we placed 29 BF-RhodoLED lamps, an increase of 123% over 1Q 2023, illustrating the need and demand we continue ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biofrontera-inc-reports-first-quarter-204500322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BFRI","BK4007","BFRIW","PDT"],"gpt_icon":0},{"id":"2435144588","title":"Biofrontera Inc    expected to post a loss of $1.17 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2435144588","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2435144588?lang=en_us&edition=fundamental","pubTime":"2024-05-14 05:08","pubTimestamp":1715634485,"startTime":"0","endTime":"0","summary":"* Biofrontera Inc     is expected to show a rise in quarterly revenue when it reports  results on May 15 for the period ending January 1 0001   * The Woburn Massachusetts-based  company is expected to","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI"],"gpt_icon":0},{"id":"2434852514","title":"Novavax, Macrogenics, Biofrontera among healthcare movers","url":"https://stock-news.laohu8.com/highlight/detail?id=2434852514","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2434852514?lang=en_us&edition=fundamental","pubTime":"2024-05-10 22:00","pubTimestamp":1715349627,"startTime":"0","endTime":"0","summary":"Gainers: Novavax  +134%. ITeos Therapeutics  +39%. Caredx  +27%. Adma Biologics  +21%. Sensus Healthcare  +19%.  Losers: Macrogenics  -71%. Progyny  -23%. Biofrontera  -16%. Protalix BioTherapeutics  -14%. Revance Therapeutics  -13%.  S&P 500 Health Care Sector +0.12% to 1670.59. Health Care Equipment & Services +0.12% to 1938.81. Pharmaceuticals, Biotechnology & Life Science which contributes 58% to index is +0.18% to 1369.27.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4104635-novavax-macrogenics-biofrontera-among-healthcare-movers","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["SH","OEF","ITOS","SSO","BK4585","BK4534","CDNA",".SPX","VOO","BFRI","BK4559","RVNC","BK4082","BK4550","SRTS","ADMA","UPRO","IVV","SDS","BK4139","ESmain","BK4581","BK4007","BK4154","LU0053671581.USD","PGNY","BK4588","SPY","MGNX","NVAX","BK4504","PLX","SPXU","BK4568","OEX"],"gpt_icon":0},{"id":"2433086674","title":"Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2433086674","media":"ACCESSWIRE","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2433086674?lang=en_us&edition=fundamental","pubTime":"2024-05-06 22:30","pubTimestamp":1715005800,"startTime":"0","endTime":"0","summary":"WOBURN, MA / ACCESSWIRE / May 6, 2024 / Biofrontera Inc. , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that it will report financial results for the three months ended March 29, 2024 on Wednesday, May 15, 2024. The results will be released after the market close on Wednesday, May 15 and the company will host a conference call on Thursday, May 16 at 10:00am Eastern Time.Webcast | Biofrontera Inc. First Quarter 2024 Financial Results and Business Update Conference Call . Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy  and topical antibiotics. The Company's licensed products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection. For more information, visit www.biofrontera-us.com.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biofrontera-inc-report-first-quarter-143000631.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BFRIW","BK4007","PDT","BFRI"],"gpt_icon":0},{"id":"2432189834","title":"Biofrontera files to sell 11.31M shares for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2432189834","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2432189834?lang=en_us&edition=fundamental","pubTime":"2024-05-04 01:11","pubTimestamp":1714756287,"startTime":"0","endTime":"0","summary":"Biofrontera (NASDAQ:BFRI) filed a prospectus on Friday related to the proposed resale of 11.31M shares of common stock by selling stockholders.\nThis prospectus is not an offer to sell these securities.\nSEC Filing","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4099866-biofrontera-files-to-sell-1131m-shares-for-holders","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BFRI","NQmain","QQQ","BK4007","TQQQ","QLD","SQQQ",".IXIC","MNQmain","PSQ","QID"],"gpt_icon":0},{"id":"2432390897","title":"Biofrontera Milestones Extend Warrants and Boost Investor Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2432390897","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2432390897?lang=en_us&edition=fundamental","pubTime":"2024-05-03 21:32","pubTimestamp":1714743155,"startTime":"0","endTime":"0","summary":"Biofrontera (BFRI) has issued an update. Biofrontera Inc. announced it has reached key milestones set out in warrants related to a private placemen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/biofrontera-milestones-extend-warrants-and-boost-investor-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/biofrontera-milestones-extend-warrants-and-boost-investor-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BFRI","BK4007"],"gpt_icon":0},{"id":"2432727239","title":"Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants","url":"https://stock-news.laohu8.com/highlight/detail?id=2432727239","media":"ACCESSWIRE","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2432727239?lang=en_us&edition=fundamental","pubTime":"2024-05-03 20:50","pubTimestamp":1714740600,"startTime":"0","endTime":"0","summary":"WOBURN, MA / ACCESSWIRE / May 3, 2024 / Biofrontera Inc.  , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that the Board of Directors has met and certified that two criteria described in warrants to purchase Series B-3 Convertible Preferred Stock issued by the Company on February 22, 2024  have been fulfilled by the Company.The Warrants were issued pursuant to a private placement of securities in February 2024, and the exercise of the Warrants will trigger payments totaling $8 million  to the Company.Certain statements in this press release may constitute \"forward-looking statements\" within the meaning of the United States Private Securities Litigation Reform Act of 1995, as amended to date. These statements include, but are not limited to, statements relating to the securing of additional funding for the Company, the registering of the shares underlying the Warrants and the improvements in the Company's salesforce and its","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biofrontera-announces-achievement-two-milestones-125000362.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["PDT","BFRIW","BFRI","BK4007"],"gpt_icon":0},{"id":"2422624479","title":"Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals","url":"https://stock-news.laohu8.com/highlight/detail?id=2422624479","media":"ACCESSWIRE","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422624479?lang=en_us&edition=fundamental","pubTime":"2024-03-27 04:30","pubTimestamp":1711485000,"startTime":"0","endTime":"0","summary":"WOBURN, MA / ACCESSWIRE / March 26, 2024 / Biofrontera, Inc.  , a biopharmaceutical company specializing in the commercialization of dermatological products, today announced that its 2024 Annual Meeting of Stockholders will be held on June 12, 2024 and that the close of business on April 22, 2024 will be the record date for the determination of stockholders entitled to notice of and to vote at the 2024 Annual Meeting. The exact time and location of the 2024 Annual Meeting will be specified in the Company's proxy statement for the 2024 Annual Meeting.In addition, to comply with the universal proxy rules, stockholders who intend to solicit proxies in s","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PFJRH16xceH_cOOcsPIYjw--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/76b73e1af1285930cde94d0663b67002"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biofrontera-inc-announces-2024-annual-203000020.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BFRIW","BK4007","PDT","BFRI"],"gpt_icon":0},{"id":"2422301556","title":"3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2422301556","media":"InvestorPlace","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2422301556?lang=en_us&edition=fundamental","pubTime":"2024-03-25 04:05","pubTimestamp":1711310702,"startTime":"0","endTime":"0","summary":"Here’s the deal with stocks to turn $1,000 into $1 million: if you want to play, you gotta pay. I’m not just talking about the…","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://investorplace.com/2024/03/3-mind-blowing-stocks-that-could-turn-1000-into-1-million/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investorplace_stock_picks","symbols":["BK4099","TTM","BK4139","BFRI","BK4583","BK4523","TNXP","AGEN","BK4007"],"gpt_icon":0},{"id":"2420426482","title":"Analysts’ Top Healthcare Picks: Biofrontera (BFRI), Alpine Immune Sciences (ALPN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2420426482","media":"TIPRANKS","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420426482?lang=en_us&edition=fundamental","pubTime":"2024-03-19 18:50","pubTimestamp":1710845421,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Biofrontera (BFRI – Research Report), Alpine Immune ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-biofrontera-bfri-alpine-immune-sciences-alpn?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-healthcare-picks-biofrontera-bfri-alpine-immune-sciences-alpn?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["HCSG","ALPN","BFRI","BK4137","BK4139","BK4007"],"gpt_icon":0},{"id":"2420629954","title":"Q4 2023 Biofrontera Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2420629954","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420629954?lang=en_us&edition=fundamental","pubTime":"2024-03-19 13:57","pubTimestamp":1710827822,"startTime":"0","endTime":"0","summary":"Eugene Frederick Leffler; Chief Financial Officer; Biofrontera Inc. Jonathan Aschoff; Managing Director, Senior Research Analyst; Roth Capital Partners LLC. Welcome to the Biofrontera Incorporated Fourth Quarter 2023 Financial Results and Business Update Conference Call.  Please note, this event is being recorded. I would now like to turn the conference over to Andrew Barwicki with Barwicki Investor Relations. Please go ahead.Thank you, Andrew, and my thanks to everyone joining us this morning. On today's call, I'll provide an overview of our accomplishments and pipeline strategy that occurred during the second part of 2023 and how these changes helped lay the groundwork for many initiatives in 2024 and beyond. Additionally, we have had some significant successes already in the first quarter of 2024 that I will touch upon. Fred Leffler, our CFO, will","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2023-biofrontera-inc-earnings-055702133.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BFRI","BFRIW"],"gpt_icon":0},{"id":"2420419567","title":"Biofrontera GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1.21M","url":"https://stock-news.laohu8.com/highlight/detail?id=2420419567","media":"seekingalpha","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2420419567?lang=en_us&edition=fundamental","pubTime":"2024-03-18 12:39","pubTimestamp":1710736774,"startTime":"0","endTime":"0","summary":"Biofrontera press release  : Q4  GAAP EPS of $1.65  beats by $2.79.Adjusted EBITDA for the fourth quarter of 2023 was negative $3.2 million compared with negative $4.4 million for the fourth quarter of 2022.More on Biofrontera  Biofrontera stock soars on announcing private placement of up to $16M Seeking Alpha’s Quant Rating on Biofrontera Historical earnings data for Biofrontera Financial information for Biofrontera","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4080292-biofrontera-gaap-eps-of-165-beats-by-279-revenue-of-106m-misses-by-121m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha_hot_news","symbols":["BFRI"],"gpt_icon":0},{"id":"2419513421","title":"Biofrontera Inc reports results for the quarter ended in December - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2419513421","media":"Reuters","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419513421?lang=en_us&edition=fundamental","pubTime":"2024-03-16 07:10","pubTimestamp":1710544208,"startTime":"0","endTime":"0","summary":"* Biofrontera Inc    reported a quarterly adjusted loss of $1.80 per share for the quarter ended in December, higher than the same quarter last year, when the company reported EPS of $-2.80.  The mean","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BFRI"],"gpt_icon":0},{"id":"2419399251","title":"Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2419399251","media":"StreetInsider","labels":[],"top":-1,"share":"https://ttm.financial/m/news/2419399251?lang=en_us&edition=fundamental","pubTime":"2024-03-16 06:11","pubTimestamp":1710540660,"startTime":"0","endTime":"0","summary":"Conference call begins at 10:00 a.m. Eastern time on Monday, March 18, 2024WOBURN, MA / ACCESSWIRE / March 15, 2024 / Biofrontera, Inc. (NASDAQ: BFRI) (the \"Company\"), a biopharmaceutical company spec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.streetinsider.com/dr/news.php?id=22940517","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_streetinsider","symbols":["BK4007","BFRI","PDT"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biofrontera-us.com","stockEarnings":[{"period":"1week","weight":-0.05},{"period":"1month","weight":-0.0952},{"period":"3month","weight":-0.1739},{"period":"6month","weight":-0.6667},{"period":"1year","weight":-0.9103},{"period":"ytd","weight":-0.657}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":0.0291},{"period":"3month","weight":0.0414},{"period":"6month","weight":0.1429},{"period":"1year","weight":0.2628},{"period":"ytd","weight":0.1463}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company offers Ameluz, a prescription drug; and the RhodoLED lamp series for photodynamic therapy for the lesion-directed and field-directed treatment of actinic keratosis of mild-to-moderate severity on the face and scalp. It also Xepi, a prescription drug for the treatment of impetigo. The company was founded in 1997 and is headquartered in Woburn, Massachusetts.","exchange":"NASDAQ","name":"Biofrontera Inc","nameEN":"Biofrontera Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biofrontera Inc(BFRI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biofrontera Inc(BFRI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biofrontera Inc,BFRI,Biofrontera Inc股票,Biofrontera Inc股票老虎,Biofrontera Inc股票老虎国际,Biofrontera Inc行情,Biofrontera Inc股票行情,Biofrontera Inc股价,Biofrontera Inc股市,Biofrontera Inc股票价格,Biofrontera Inc股票交易,Biofrontera Inc股票购买,Biofrontera Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biofrontera Inc(BFRI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biofrontera Inc(BFRI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}